Presymptomatic signs in healthy CJD mutation carriers

Dementia and Geriatric Cognitive Disorders

Volumn 19, Issue 5-6, 2005, Pages 246-255

  Gigi, Ariela ^a,d   Vakil, Eli ^b   Kahana, Ester ^c   Hadar, Uri ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c BARZILAI MEDICAL CENTER   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

Anxiety; Creutzfeldt Jacob disease; Dementia; Neuropsychology; Preclinical signs; Prion mutation; PRNP gene

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC VALUE; DISEASE CARRIER; FAMILIAL DISEASE; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; PRIORITY JOURNAL; RELATIVE; SCORING SYSTEM; STATE TRAIT ANXIETY INVENTORY; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

AGED; AMYLOID; ANXIETY; COGNITION DISORDERS; CREUTZFELDT-JAKOB SYNDROME; FEMALE; HUMANS; ISRAEL; JEWS; MALE; MIDDLE AGED; MUTATION, MISSENSE; NEUROPSYCHOLOGICAL TESTS; PRIONS; PROTEIN PRECURSORS; RISK FACTORS;

EID: 18644377760     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084549     Document Type: Article

References (67)

1. Albert MS: Cognitive and neurobiologic markers of early Alzheimer disease. Proc Natl Acad Sci USA 1996;93:13547-13551.
2. Bernard JF, Bandler R: Parallel circuits for emotional coping behavior: New pieces in the puzzle. J Comp Neurol 1998;401:429-436.
3. Bornstein RA: Normative data on selected neuropsychological measures from a nonclinical sample. J Clin Psychol 1985;41:651-659.
4. Brandel JP, Delasnerie-Laupretre N: Creutzfeldt-Jakob disease and stress. J Neurol Neurosurg Psychiatry 1997;62:541.
5. Brown DR, Besinger A: Prion protein expression and superoxide dismutase activity. J Biochem 1998;334:423-429.
6. Chapman J, Ben-Israel J, Goldhammer Y, Korczyn AD: The risk of developing Creutzfeldt-Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology 1994;44:1683-1686.
7. Chapman J, Korczyn AD: Genetic and environmental factors determining the development of Creutzfeldt-Jakob disease in Libyan Jews. Neuroepidemiology 1991;10:228-231.
8. Cochran EJ, Bennett DA, Cervenakova L, Kenney K, Bernard B, Foster NL, Benson DF, Goldfarb LG, Brown P: Familial Creutzfeldt-Jakob disease with a five-repeat octapeptide insert mutation. Neurology 1996;47:727-733.
9. Collinge J: Creutzfeldt-Jakob disease and other prion diseases; in Obrien J. Ames D, Burns A (eds): Dementia. London, Oxford University Press, 2000, pp 863-875.
10. Craufurd D, Thompson JC, Snowden JS: Behavioral changes in Huntington disease. Neuropsychiatry Neuropsychol Behav Biol 2001;14:219-226.
11. Cubelli R, Speri V: Naming rotated pictures and the riddle of object-centred neglect. Cortex 2001;37:159-174.
12. Damian MF, Martin RC: Semantic and phonological codes interact in single word production. J Exp Psychol Learn Mem Cogn 1999;25:345-361.
13. De Kloet ER, Oitzl MS, Joels M: Stress and cognition: Are corticosteroids good or bad guys? Trends Neurosci 1999;22:422-426.
14. Diamond R, White RF, Myers RH, Mastromauro C, Koroshetz WJ, Butters N, Rothstein DM, Moss MB, Vasterling J: Evidence of presymptomatic cognitive decline in Huntington's disease. J Clin Exp Neuropsychol 1992;14:961-975.
15. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
16. Foroud T, Siemers E, Kleindorfer D, Bill DJ, Hodes ME, Norton JA, Conneally PM, Christian JC: Cognitive scores in carriers of Huntington's disease gene compared to noncarriers. Ann Neurol 1995;37:657-664.
17. Forstl H: What is Alzheimer's disease? In Obrien J, Ames D, Burns A (eds): Dementia. London, Oxford University Press, 2000, pp 371-383.
18. Fox NC, Warrington AL, Seiffer AL, Agnew SK, Rosser MN: Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. Brain 1998;121:1631-1639.
19. Frank EM, McDade HL, Scott WK: Naming in dementia secondary to Parkinson's, Huntington's, and Alzheimer's diseases. J Commun Disord 1996;29:183-197.
20. Gass CS: Familial CJD: A neuropsychological case report. Arch Clin Neuropsychol 2000;15:165-175.
21. Gigi A, Kahana E, Vakil E, Hadar U, Prohovnik I: Neuropsychological assessment in early Creutzfeldt-Jakob disease. Soc Neurosci Abstr 1999;25:739.12.
22. Gigi A, Kahana E, Vakil E, Hadar U, Prohovnik I: Neuropsychological assessment in early Creutzfeldt-Jakob disease. Neurosci Lett 1998(suppl 51):S13.
23. Gigi A, Kahana E, Hadar U: Healthy Creutzfeldt-Jakob disease mutation carriers have abnormality in anxiety reported scores (STAS). Society for Neuroscience Abstracts, 2001.
24. Goldfarb LG, Korczyn AD, Brown P, Chapman J, Gajdusek DC: Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet 1990;336:637-638.
25. Gomez-Tortosa E, del Barrio A, Sanchez PR, Benitez J, Barroso A, Garcia YJ: Cognitive assessment of asymptomatic Huntington's disease carrier. Neurologia 1997;12:226-231.
26. Hadar U, Rose FC: Neuropsychological assessment of cognitive change in dementia. Neuroepidemiology 1990;9:189-192.
27. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G: Wisconsin Card Sorting Test Manual (revised and expanded). Lutz/Fla, Psycholgical Assessment Resources, Inc, 1993.
28. Heilman KM, Valentin E: Clinical Neuropsychology, ed 3. London, Oxford University Press, 1993.
29. Hendler T, Rotstein P, Hadar U: Emotion-perception interplay in the visual cortex: 'The eyes follow the heart'. Cell Mol Neurobiol 2001;21:733-752.
30. Huber SJ, Shuttleworth EC, Pauslson GW, Bellchambers MJ, Clapp LE: Cortical and subcortical dementia: Neuropsychological differences. Arch Neurol 1986;43:392-394.
31. Ironside JW: Prion diseases: Update on Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 1996;22:446.
32. Jacobs DM: The role of neuropsychological testing in neurological disease. Neurol Update 1998;3:139-143.
33. Kahana E, Zilber N, Abraham M: Do Creutzfeldt-Jakob disease patients of Jewish Libyan origin have unique clinical features? Neurology 1991;41:1390-1392.
34. Kasckow JW, Baker D, Geracioti TD: Corticotrophin-releasing hormone in depression and post-traumatic stress disorder. Peptides 2001;22:845-851.
35. Knight R: Creutzfeldt-Jakob disease: Clinical features, epidemiology and tests. Electrophoresis. 1998;19:1306-1310.
36. Knopman DS: The initial diagnosis and recognition of dementia. Am J Med 1998;104:S2-S12.
37. Kovanen J: Clinical characteristics of familial and sporadic Creutzfeldt-Jakob disease in Finland. Acta Neurol Scand 1993;87:469-474.
38. Laiaona M, Luzzatti C, Zonca G, Guarnaschelli C, Capitani E: Lexical and semantic factors influencing picture naming in aphasia. Brain Cogn 2001;46:184-187.
39. Lalonde FM, Martin AM, Myslobodsky MS: Increased prevalence of septal cavitation in a nonschizophrenic sample: An MRI study of HIV-infected individuals. J Neuropsychiatry Clin Neurosci 1995;8:47-53.
40. Laske C, Gefeller O, Pfahlberg A, Zerr I, Schroter A, Poser S: The effect of stress on the onset and progression of Creutzfeldt-Jakob disease: Results of a German pilot case-control study. Eur J Epidemiol 1999;15:631-635.
41. Lezak MD: Neuropsychological Assessment, ed 3. London, Oxford University Press, 1995.
42. Levelt WJ, Roelofs A, Meyer AS: A theory of lexical access in speech production. Behav Brain Sci 1999;22:1-38.
43. Levin BE, Tomer R, Rey GJ: Cognitive impairments in Parkinson's disease. Neurol Clin 1992;10:471-485.
44. McEwen BS: Neuroendocrine interactions; in Bloom FE, Kupfer DJ (eds): Psychopharmacology. New York, Raven Press, 1995, chapt 62, p 705.
45. Margorie N, Loraine KO, Rhoda A, Martin LA: On the nature of naming errors in aging and dementia. Brain Lang 1996;54:184-195.
46. Mathew SJ, Coplan JD, Gorman JM: Neurobiological mechanisms of social anxiety disorder. Am J Psychiatry 2001;158:1558-1567.
47. Merola B, Longobardi S, Colao A, Di Somma C, Ferone D, Rossi E, Covelli V, Lombardi G: Hypothalamic-pituitary-adrenal axis in neuropsychiatric disorders. Ann NY Acad Sci 1994;741:263-270.
48. Nicholson KG, Humphrey GK: Surface cues reduce the latency to name rotated images of objects. Perception 2001;30:1057-1081.
49. Prusiner SB: The prion diseases. Brain Pathol 1998;8:499-513.
50. Reitan RM: Validity of the Trail-Making test as an indicator of organic brain damage. Percept Memory Skills 1958;8:271-276.
51. Rosenberg NK, Sorensen SA, Christensen AL: Neuropsychological characteristics of Huntington's disease carriers: A double-blind study. J Med Genet 1995;32:600-604.
52. Rotstein P, Malach R, Hadar U, Graif M, Hendler T: Feeling or features: Different sensitivity to emotion in high-order visual cortex and amygdala. Neuron 2001;32:747-757.
53. Sapolsky RM: Stress, the Aging Brain, and the Mechanisms of Neuron Death. London, MIT Press, 1992.
54. Scott LR, Cary RS, Nathaniel MA, Alan JF, Michael AJ: The functional neuroanatomy of anxiety: A study of three disorders using positron emission tomography and symptom provocation. Biol Psychiatry 1997;42:446-452.
55. Simon ES, Kahana E, Chapman J, Treves TA, Gabizon R, Rosenmann H, Zilber N, Korczyn AD: Creutzfeldt-Jakob disease profile in patients homozygous for the PRNP E200K mutation. Ann Neurol 2000;47:257-260.
56. Small GW, Ercoli LM, Silverman DH, Hung SC, Komo S, et al.: Cerebral metabolic and cognitive decline in persons at risk for Alzheimer's disease. Proc Natl Acad Sci USA 2000;97:6037-6042.
57. Spree O, Strous EA: Compendium of Neuropsychological Tests. New York, Oxford University Press, 1991.
58. Stuss DT, Sarazin FF, Leech EE, Picton TW: Event-related potentials during naming and mental rotation. Electroencephalogr Clin Neurophysiol 1983;56:133-146.
59. Tatzelt J, Voellmy R, Welch WJ: Abnormalities in stress proteins in prion diseases. Cell Mol Neurobiol 1998;18:721-729.
60. Telling GC, Scott M, Hsiao KK, Foster D, Yang SL, Torchia M, Sidle KCL, Collinge J, DeArmond SJ, Prusiner SB: Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci USA 1994;91:9936-9940.
61. Tierney MC: Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 2001;57:163-164.
62. Vakil E, Blachstein H: A supplementary measure in the Rey AVLT for assessing incidental learning of temporal order. J Clin Psychol 1994;50:240-245.
63. Vakil E, Blachstein H: Rey AVLT: Developmental norms for adults and the sensitivity of different memory measures to age. Clin Neuropsychol 1997;11:1-14.
64. Van Duijn CM, Delasnerie-Laupretre N, Masullo C, et al: Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-1995. Lancet 1998;351:1081-1085.
65. Wechsler D: WAIS-RManual. New York, Psychological Corp, 1981.
66. Wechsler D: WMS-R Manual. New York, Psychological Corp, 1987.
67. Warrington EK, Taylor AM: The contribution of the right parietal lobe to object recognition. Cortex 1973;9:152-164.